These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa. Mojica MF, De La Cadena E, Hernández-Gómez C, Correa A, Appel TM, Pallares CJ, Villegas MV. J Glob Antimicrob Resist; 2020 Jun; 21():391-395. PubMed ID: 32004722 [Abstract] [Full Text] [Related]
9. Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections. Kansak N, Arıcı N, Adaleti R, Nakipoglu Y, Aksaray S. J Microbiol Methods; 2021 Sep; 188():106296. PubMed ID: 34333048 [Abstract] [Full Text] [Related]
10. In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures. de Cueto M, López L, Hernández JR, Morillo C, Pascual A. Antimicrob Agents Chemother; 2006 Jan; 50(1):368-70. PubMed ID: 16377714 [Abstract] [Full Text] [Related]
11. In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae. Aprile A, Scalia G, Stefani S, Mezzatesta ML. J Glob Antimicrob Resist; 2020 Dec; 23():286-289. PubMed ID: 33045444 [Abstract] [Full Text] [Related]
14. Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study. Tellapragada C, Hasan B, Antonelli A, Maruri A, de Vogel C, Gijón D, Coppi M, Verbon A, van Wamel W, Rossolini GM, Cantón R, Giske CG. Clin Microbiol Infect; 2020 Oct; 26(10):1413.e1-1413.e7. PubMed ID: 32006694 [Abstract] [Full Text] [Related]
16. Evaluation of a Commercial Broth Microdilution Panel for Colistin Susceptibility Testing of Clinical Isolates of Escherichia coli and Klebsiella pneumoniae. Mirza HC, Bıçakçıgil A, Liste Ü, Sancak B. Clin Lab; 2021 May 01; 67(5):. PubMed ID: 33978373 [Abstract] [Full Text] [Related]
17. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. Lee SY, Park YJ, Yu JK, Jung S, Kim Y, Jeong SH, Arakawa Y. J Antimicrob Chemother; 2012 Dec 01; 67(12):2843-7. PubMed ID: 22893681 [Abstract] [Full Text] [Related]
18. The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates. Elliott ZS, Barry KE, Cox HL, Stoesser N, Carroll J, Vegesana K, Kotay S, Sheppard AE, Wailan A, Crook DW, Parikh H, Mathers AJ. J Clin Microbiol; 2019 Oct 01; 57(10):. PubMed ID: 31340992 [Abstract] [Full Text] [Related]
19. [Investigation of Fosfomycin Susceptibility in Extended Spectrum Beta-Lactamase Producing Enteric Bacteria by Disk Diffusion, Automated System and Agar Dilütion Kit]. Soydan G, Görgülü Y, Öztürk C. Mikrobiyol Bul; 2021 Oct 01; 55(4):617-625. PubMed ID: 34666660 [Abstract] [Full Text] [Related]
20. Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates. Galani I, Adamou P, Karaiskos I, Giamarellou H, Souli M. J Glob Antimicrob Resist; 2018 Dec 01; 15():123-126. PubMed ID: 30036693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]